James J. Vaughn, Chief Commercial Officer at GENOMIC HEALTH INC (GHDX), sold 4,500 shares at $72.80 ($332K) on 2019-08-08, disclosed to the SEC on 2019-08-12.
Scheduled sale ($332k) by Chief Commercial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $72.80 | 397 | $29K | 8.7% |
| 2 | $73.56 | 1,723 | $127K | 38.2% |
| 3 | $73.57 | 700 | $51K | 15.5% |
| 4 | $74.20 | 403 | $30K | 9.0% |
| 5 | $74.21 | 1,277 | $95K | 28.6% |
| Total | $73.74 avg | 4,500 |
| $332K |
| 100% |
| Filing → |
| GHDX | SELL | 2019-07-09 | $399K | — | Filing → |
| GHDX | SELL | 2019-06-10 | $61K | — | Filing → |
| GHDX | SELL | 2019-05-10 | $362K | — | Filing → |